TGR5’s stimulating effect on CCA growth seems to occur by a dual mechanism; (i) increased proliferation for stimulation of the EGFR/ERK1/2 pathway; and (ii) inhibition of apoptosis by a cAMP/PKA/CD95 cascade [62]. Here, EGFR is linked to cholangiocarcinoma.